SCHEMBL26415895

SCHEMBL26415895

c1ccc(-c2cc(-c3ccccc3)nc(-c3cccc4oc5cc(-n6c7ccc8ccccc8c7c7c8ccccc8ccc76)ccc5c34)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.36
ALDH1A1 P00352 5/20 0.36
KDM4E B2RXH2 4/20 0.36
HPGD P15428 4/20 0.36
TDP1 Q9NUW8 4/20 0.34
L3MBTL1 Q9Y468 3/20 0.34
ABCG2 Q9UNQ0 3/20 0.34
CYP1A2 P05177 3/20 0.34
CYP1A1 P04798 1/20 0.34
FYN P06241 1/20 0.34
MAPK3 P27361 1/20 0.34
AHR P35869 1/20 0.34
PAX8 Q06710 1/20 0.34
MAPK1 P28482 3/20 0.33
KMT2A Q03164 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
PTGER4 P35408 1/20 0.33
TP53 P04637 1/20 0.33
TSHR P16473 1/20 0.33
NFKB1 P19838 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21863150 0.93 MAPT (0.36) MAPTALDH1A1KDM4EHPGDTDP1
SCHEMBL21863022 0.91 TDP1 (0.34) MAPTALDH1A1KDM4EHPGDTDP1
SCHEMBL21862736 0.90 CYP1A1 (0.35) MAPTALDH1A1KDM4EHPGDTDP1
SCHEMBL24118957 0.89 ALDH1A1 (0.34) MAPTALDH1A1KDM4EHPGDTDP1
SCHEMBL23740552 0.88 ALDH1A1 (0.33) MAPTALDH1A1KDM4EHPGDTDP1
SCHEMBL23740656 0.88 TDP1 (0.33) MAPTALDH1A1KDM4EHPGDTDP1
SCHEMBL21666975 0.88 TDP1 (0.34) MAPTALDH1A1KDM4EHPGDTDP1
SCHEMBL24217323 0.88 MAPT (0.34) MAPTALDH1A1KDM4EHPGDTDP1
SCHEMBL23740525 0.88 TDP1 (0.34) MAPTALDH1A1TDP1L3MBTL1ABCG2
SCHEMBL26416061 0.87 KDM4E (0.37) MAPTALDH1A1KDM4EHPGDTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE CRY1, ORC3, ODC1 MAPT 950/4885ALDH1A1 27/4885KDM4E 3080/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.